HIV drug could be breakthrough for millions with untreatable throat condition
NCT ID NCT04383262
Summary
This study is testing whether an existing HIV medication can help people with laryngopharyngeal reflux (LPR), a common throat condition that causes chronic cough, hoarseness, and throat clearing. Researchers will give 104 adults with LPR either the HIV drug fosamprenavir or a placebo pill for 12 weeks to see if it reduces their symptoms. The study focuses on patients who haven't improved with standard acid-reducing medications, testing a new approach that targets a different cause of throat damage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARYNGOPHARYNGEAL REFLUX are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Froedtert Hospital
Milwaukee, Wisconsin, 53226, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.